Nakayama S
Nihon Yakurigaku Zasshi. 1979 Sep;75(6):571-84.
The mechanism of liver enlargement and anti-fatty liver effect of NKK-105 in the rat were investigated by the mesurement of drug-metabolizing enzyme activities and morphological changes in liver tissue detected using electron microscopy. A single administration of NKK-105(250, 500, 1000 mg/kg, p.o.) induced an apparent increase in liver weight. The elevation of aminopyrine demethylase activity and slight increase in microsomal cytochrome b5 and cytochrome P-450 content were seen with the administration of NKK-105. NKK-105 inhibited lipid peroxide formation in mitochondrial and microsomal fractions. Total lipid content of liver decreased at 12 hr after the administration of NKK-105. Lipid peroxide formation in mitochondrial and microsomal fractions was markedly inhibited by the addition of NKK-105 (1 X 10(-3)M), in vitro. Disarrangement of rough endoplasmic reticulum and increase in smooth endoplasmic reticulum were observed by the administration of NKK-105. The decrease in drug-metabolizing enzymes caused by CCl4 or ethionine was protected in the combination with NKK-105. NKK-105 markedly inhibited the elevation of lipid peroxide formation caused by CCl4 or ethionine. Similar effects on lipid peroxide formation were also obtained in vitro. These results suggest that the enlargement induced by NKK-105 indicates a functional not a toxic response. The inhibition of lipid peroxide formation in mitochondrial and microsomal fractions may thus play an important role in the mechanism of anti-fatty liver effect of NKK-105 on the CCl4 or ethionine-induced fatty liver.
通过测定药物代谢酶活性以及使用电子显微镜检测肝组织的形态变化,研究了NKK - 105对大鼠肝脏肿大和抗脂肪肝作用的机制。单次口服给予NKK - 105(250、500、1000毫克/千克)可使肝脏重量明显增加。给予NKK - 105后,可见氨基比林脱甲基酶活性升高,微粒体细胞色素b5和细胞色素P - 450含量略有增加。NKK - 105抑制线粒体和微粒体部分脂质过氧化物的形成。给予NKK - 105后12小时,肝脏总脂质含量降低。体外实验中,加入NKK - 105(1×10⁻³M)可显著抑制线粒体和微粒体部分脂质过氧化物的形成。给予NKK - 105后,观察到粗面内质网排列紊乱和平滑内质网增加。与NKK - 105联合使用可保护由四氯化碳或乙硫氨酸引起的药物代谢酶降低。NKK - 105显著抑制由四氯化碳或乙硫氨酸引起的脂质过氧化物形成升高。在体外实验中也获得了对脂质过氧化物形成的类似作用。这些结果表明,NKK - 105引起的肝脏肿大表明是一种功能性而非毒性反应。因此,线粒体和微粒体部分脂质过氧化物形成的抑制可能在NKK - 105对四氯化碳或乙硫氨酸诱导的脂肪肝的抗脂肪肝作用机制中起重要作用。